(Reuters) - Corning Inc said on Friday it would receive an additional funding of $57 million from the U.S. government to increase its domestic manufacturing capacity of pharmaceutical glass tubing and vials to support the development of COVID-19 vaccine. The new funding is in addition to a $204 million contract the company received in June 2020, Corning said. Reporting by Dania Nadeem in Bengaluru; Editing by Vinay Dwivedi